Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Atropine Market Report for Period 2018 till 2026

Single User: $2999
Multiple User: $3999
Enterprise User: $4999


Report Summary:

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.

Scope of the Report:
This report focuses on the Atropine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
C2PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng Group
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Injection
Drop
Gel

Market Segment by Applications, can be divided into
Gastrointestinal
Ophthalmology
Other

There are 15 Chapters to deeply display the global Atropine market.

Chapter 1, to describe Atropine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Atropine, with sales, revenue, and price of Atropine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Atropine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Atropine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Atropine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Atropine Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Drop
1.2.3 Gel
1.3 Market Analysis by Applications
1.3.1 Gastrointestinal
1.3.2 Ophthalmology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 C2PHARMA
2.1.1 Business Overview
2.1.2 Atropine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 C2PHARMA Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 RESONANCE LABORATORIES
2.2.1 Business Overview
2.2.2 Atropine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 RESONANCE LABORATORIES Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 ROLABO OUTSOURCING
2.3.1 Business Overview
2.3.2 Atropine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 ROLABO OUTSOURCING Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Minsheng Group
2.4.1 Business Overview
2.4.2 Atropine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Minsheng Group Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 CR Double-Crane
2.5.1 Business Overview
2.5.2 Atropine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 CR Double-Crane Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 HENAN PURUI
2.6.1 Business Overview
2.6.2 Atropine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 HENAN PURUI Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Albany Molecular Research
2.7.1 Business Overview
2.7.2 Atropine Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Albany Molecular Research Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Alchem International
2.8.1 Business Overview
2.8.2 Atropine Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Alchem International Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SAURAV CHEMICALS
2.9.1 Business Overview
2.9.2 Atropine Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 SAURAV CHEMICALS Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Katsura Chemical
2.10.1 Business Overview
2.10.2 Atropine Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Katsura Chemical Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hangzhou Vega
2.11.1 Business Overview
2.11.2 Atropine Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Hangzhou Vega Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Wuhan senwayer century
2.12.1 Business Overview
2.12.2 Atropine Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Wuhan senwayer century Atropine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Atropine Market Competition, by Manufacturer
3.1 Global Atropine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Atropine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Atropine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Atropine Manufacturer Market Share in 2017
3.4.2 Top 5 Atropine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Atropine Market Analysis by Regions
4.1 Global Atropine Sales, Revenue and Market Share by Regions
4.1.1 Global Atropine Sales by Regions (2013-2018)
4.1.2 Global Atropine Revenue by Regions (2013-2018)
4.2 North America Atropine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Atropine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Atropine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Atropine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Atropine Sales, Revenue and Growth Rate (2013-2018)
5 North America Atropine by Countries, Type, Application and Manufacturers
5.1 North America Atropine Sales, Revenue and Market Share by Countries
5.1.1 North America Atropine Sales by Countries (2013-2018)
5.1.2 North America Atropine Revenue by Countries (2013-2018)
5.1.3 United States Atropine Sales and Growth Rate (2013-2018)
5.1.4 Canada Atropine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Atropine Sales and Growth Rate (2013-2018)
5.2 North America Atropine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Atropine Sales by Manufacturers (2016-2017)
5.2.2 North America Atropine Revenue by Manufacturers (2016-2017)
5.3 North America Atropine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Atropine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Atropine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Atropine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Atropine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Atropine Revenue and Revenue Share by Application (2013-2018)
6 Europe Atropine by Countries, Type, Application and Manufacturers
6.1 Europe Atropine Sales, Revenue and Market Share by Countries
6.1.1 Europe Atropine Sales by Countries (2013-2018)
6.1.2 Europe Atropine Revenue by Countries (2013-2018)
6.1.3 Germany Atropine Sales and Growth Rate (2013-2018)
6.1.4 UK Atropine Sales and Growth Rate (2013-2018)
6.1.5 France Atropine Sales and Growth Rate (2013-2018)
6.1.6 Russia Atropine Sales and Growth Rate (2013-2018)
6.1.7 Italy Atropine Sales and Growth Rate (2013-2018)
6.2 Europe Atropine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Atropine Sales by Manufacturers (2016-2017)
6.2.2 Europe Atropine Revenue by Manufacturers (2016-2017)
6.3 Europe Atropine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Atropine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Atropine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Atropine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Atropine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Atropine Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Atropine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Atropine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Atropine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Atropine Revenue by Countries (2013-2018)
7.1.3 China Atropine Sales and Growth Rate (2013-2018)
7.1.4 Japan Atropine Sales and Growth Rate (2013-2018)
7.1.5 Korea Atropine Sales and Growth Rate (2013-2018)
7.1.6 India Atropine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Atropine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Atropine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Atropine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Atropine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Atropine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Atropine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Atropine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Atropine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Atropine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Atropine Revenue and Revenue Share by Application (2013-2018)
8 South America Atropine by Countries, Type, Application and Manufacturers
8.1 South America Atropine Sales, Revenue and Market Share by Countries
8.1.1 South America Atropine Sales by Countries (2013-2018)
8.1.2 South America Atropine Revenue by Countries (2013-2018)
8.1.3 Brazil Atropine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Atropine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Atropine Sales and Growth Rate (2013-2018)
8.2 South America Atropine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Atropine Sales by Manufacturers (2016-2017)
8.2.2 South America Atropine Revenue by Manufacturers (2016-2017)
8.3 South America Atropine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Atropine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Atropine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Atropine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Atropine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Atropine Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Atropine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Atropine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Atropine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Atropine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Atropine Sales and Growth Rate (2013-2018)
9.1.4 UAE Atropine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Atropine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Atropine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Atropine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Atropine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Atropine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Atropine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Atropine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Atropine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Atropine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Atropine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Atropine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Atropine Revenue and Revenue Share by Application (2013-2018)
10 Global Atropine Market Segment by Type
10.1 Global Atropine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Atropine Sales and Market Share by Type (2013-2018)
10.1.2 Global Atropine Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2013-2018)
10.2.2 Global Injection Price (2013-2018)
10.3 Drop Sales Growth and Price
10.3.1 Global Drop Sales Growth (2013-2018)
10.3.2 Global Drop Price (2013-2018)
10.4 Gel Sales Growth and Price
10.4.1 Global Gel Sales Growth (2013-2018)
10.4.2 Global Gel Price (2013-2018)
11 Global Atropine Market Segment by Application
11.1 Global Atropine Sales Market Share by Application (2013-2018)
11.2 Gastrointestinal Sales Growth (2013-2018)
11.3 Ophthalmology Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Atropine Market Forecast (2018-2023)
12.1 Global Atropine Sales, Revenue and Growth Rate (2018-2023)
12.2 Atropine Market Forecast by Regions (2018-2023)
12.2.1 North America Atropine Market Forecast (2018-2023)
12.2.2 Europe Atropine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Atropine Market Forecast (2018-2023)
12.2.4 South America Atropine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Atropine Market Forecast (2018-2023)
12.3 Atropine Market Forecast by Type (2018-2023)
12.3.1 Global Atropine Sales Forecast by Type (2018-2023)
12.3.2 Global Atropine Market Share Forecast by Type (2018-2023)
12.4 Atropine Market Forecast by Application (2018-2023)
12.4.1 Global Atropine Sales Forecast by Application (2018-2023)
12.4.2 Global Atropine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 39940

Category: 11

Published date: 2018-05-23 07:41:52

Number of Pages: 105

Publisher Name: GIR

Over all Rating: 91 % (Average of Ratings provided by clients)